Annual FCF
-$529.03 M
-$103.21 M-24.24%
December 31, 2023
Summary
- As of February 12, 2025, BBIO annual free cash flow is -$529.03 million, with the most recent change of -$103.21 million (-24.24%) on December 31, 2023.
- During the last 3 years, BBIO annual FCF has fallen by -$121.79 million (-29.91%).
- BBIO annual FCF is now -1191.82% below its all-time high of -$40.95 million, reached on December 31, 2017.
Performance
BBIO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$182.30 M
-$254.55 M-352.29%
September 30, 2024
Summary
- As of February 12, 2025, BBIO quarterly free cash flow is -$182.30 million, with the most recent change of -$254.55 million (-352.29%) on September 30, 2024.
- Over the past year, BBIO quarterly FCF has dropped by -$57.04 million (-45.54%).
- BBIO quarterly FCF is now -352.29% below its all-time high of $72.26 million, reached on June 30, 2024.
Performance
BBIO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$456.32 M
-$36.64 M-8.73%
September 30, 2024
Summary
- As of February 12, 2025, BBIO TTM free cash flow is -$456.32 million, with the most recent change of -$36.64 million (-8.73%) on September 30, 2024.
- Over the past year, BBIO TTM FCF has increased by +$72.70 million (+13.74%).
- BBIO TTM FCF is now -1277.46% below its all-time high of -$33.13 million, reached on March 31, 2018.
Performance
BBIO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
BBIO Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.2% | -45.5% | +13.7% |
| 3 y3 years | -29.9% | -45.5% | +13.7% |
| 5 y5 years | -241.7% | -45.5% | +13.7% |
BBIO Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.2% | +3.1% | -352.3% | +17.5% | -11.7% | +24.7% |
| 5 y | 5-year | -106.5% | +3.1% | -352.3% | +17.5% | -78.1% | +24.7% |
| alltime | all time | -1191.8% | +3.1% | -352.3% | +17.5% | -1277.5% | +24.7% |
BridgeBio Pharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$182.30 M(-352.3%) | -$456.32 M(+8.7%) |
| Jun 2024 | - | $72.26 M(-132.7%) | -$419.68 M(-30.7%) |
| Mar 2024 | - | -$221.03 M(+76.5%) | -$605.72 M(+14.5%) |
| Dec 2023 | -$529.03 M(+24.2%) | -$125.25 M(-14.0%) | -$529.03 M(+6.3%) |
| Sep 2023 | - | -$145.66 M(+28.0%) | -$497.82 M(+2.0%) |
| Jun 2023 | - | -$113.78 M(-21.2%) | -$488.08 M(+19.4%) |
| Mar 2023 | - | -$144.33 M(+53.5%) | -$408.65 M(-4.0%) |
| Dec 2022 | -$425.81 M(-22.0%) | -$94.04 M(-30.8%) | -$425.81 M(-9.1%) |
| Sep 2022 | - | -$135.92 M(+295.6%) | -$468.20 M(-5.5%) |
| Jun 2022 | - | -$34.35 M(-78.7%) | -$495.30 M(-10.7%) |
| Mar 2022 | - | -$161.49 M(+18.4%) | -$554.95 M(+1.6%) |
| Dec 2021 | -$546.18 M | -$136.43 M(-16.3%) | -$546.18 M(+7.5%) |
| Sep 2021 | - | -$163.02 M(+73.4%) | -$508.16 M(+6.4%) |
| Jun 2021 | - | -$94.00 M(-38.5%) | -$477.37 M(+1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$152.73 M(+55.2%) | -$471.56 M(+15.8%) |
| Dec 2020 | -$407.23 M(+58.9%) | -$98.41 M(-25.6%) | -$407.23 M(+6.0%) |
| Sep 2020 | - | -$132.23 M(+49.9%) | -$384.27 M(+27.1%) |
| Jun 2020 | - | -$88.19 M(-0.2%) | -$302.42 M(+6.8%) |
| Mar 2020 | - | -$88.40 M(+17.2%) | -$283.06 M(+10.5%) |
| Dec 2019 | -$256.23 M(+65.5%) | -$75.45 M(+49.8%) | -$256.23 M(+12.4%) |
| Sep 2019 | - | -$50.38 M(-26.8%) | -$227.93 M(+5.3%) |
| Jun 2019 | - | -$68.83 M(+11.8%) | -$216.48 M(+18.1%) |
| Mar 2019 | - | -$61.57 M(+30.6%) | -$183.26 M(+18.4%) |
| Dec 2018 | -$154.82 M(+278.1%) | -$47.16 M(+21.1%) | -$154.82 M(+43.8%) |
| Sep 2018 | - | -$38.93 M(+9.3%) | -$107.67 M(+56.6%) |
| Jun 2018 | - | -$35.61 M(+7.5%) | -$68.74 M(+107.5%) |
| Mar 2018 | - | -$33.13 M | -$33.13 M |
| Dec 2017 | -$40.95 M | - | - |
FAQ
- What is BridgeBio Pharma annual free cash flow?
- What is the all time high annual FCF for BridgeBio Pharma?
- What is BridgeBio Pharma annual FCF year-on-year change?
- What is BridgeBio Pharma quarterly free cash flow?
- What is the all time high quarterly FCF for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly FCF year-on-year change?
- What is BridgeBio Pharma TTM free cash flow?
- What is the all time high TTM FCF for BridgeBio Pharma?
- What is BridgeBio Pharma TTM FCF year-on-year change?
What is BridgeBio Pharma annual free cash flow?
The current annual FCF of BBIO is -$529.03 M
What is the all time high annual FCF for BridgeBio Pharma?
BridgeBio Pharma all-time high annual free cash flow is -$40.95 M
What is BridgeBio Pharma annual FCF year-on-year change?
Over the past year, BBIO annual free cash flow has changed by -$103.21 M (-24.24%)
What is BridgeBio Pharma quarterly free cash flow?
The current quarterly FCF of BBIO is -$182.30 M
What is the all time high quarterly FCF for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly free cash flow is $72.26 M
What is BridgeBio Pharma quarterly FCF year-on-year change?
Over the past year, BBIO quarterly free cash flow has changed by -$57.04 M (-45.54%)
What is BridgeBio Pharma TTM free cash flow?
The current TTM FCF of BBIO is -$456.32 M
What is the all time high TTM FCF for BridgeBio Pharma?
BridgeBio Pharma all-time high TTM free cash flow is -$33.13 M
What is BridgeBio Pharma TTM FCF year-on-year change?
Over the past year, BBIO TTM free cash flow has changed by +$72.70 M (+13.74%)